ARTICLE | Clinical News
DigiFab regulatory update
February 7, 2011 8:00 AM UTC
BTG's marketing partner Paladin Labs Inc. (TSX:PLB, Montreal, Quebec) said Health Canada approved DigiFab to treat digoxin toxicity or overdose. The polyclonal antibody against digoxin (digitalis) g...